Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility

Author： Ruiz-Nuno A.   Villarroya M.   Cano-Abad M.   Rosado A.   Balfagon G.   Lopez M.G.   Garca A.G.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.411, Iss.3, 2001-01, pp. : 289-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of migraine with prophylactic drugs

By Evers Stefan  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2565-2573

Informa Healthcare

Access to resources Recommend Favorite

The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation

By Williamson D.J.   Shepheard S.L.   Hill R.G.   Hargreaves R.J.  

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 61-64

Elsevier

Access to resources Recommend Favorite

New and Emerging Prophylactic Agents for Migraine

By Krymchantowski A.V.  

CNS Drugs, Vol. 16, Iss. 9, 2002-01 ,pp. : 611-634

Adis International

Access to resources Recommend Favorite

Prophylactic nadolol or topiramate boosts QOL in migraine

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 537, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Migraine prophylactic drugs –– something new under the sun?

By Bekkelund Svein I   Alstadhaug Karl B  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 9, 2011-09 ,pp. : 1201-1210

Informa Healthcare

Access to resources Recommend Favorite